Click Chemistry and Multicomponent Reaction for Linker Diversification of Zinc Dipicolylamine-Based Drug Conjugates
Open Access
- 15 February 2022
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Chemistry
- Vol. 9, 822587
Abstract
An efficient Ugi multicomponent reaction with strain promoted azide-alkyne cycloaddition protocol has been utilized in concert or independently to prepare a small family of bioactive zinc(II) dipicolylamine (ZnDPA)-based SN-38 conjugates. With sequential click chemistry coupling between the cytotoxic payload and phosphatidylserine-targeting ZnDPA ligand derived from structurally diverse carboxylic acids, aldehyde or ketones, and isocyanides, we demonstrated that this convergent synthetic strategy could furnish conjugates harnessing diversified linkers that exhibited different pharmacokinetic profiles in systemic circulation in vivo. Among the eight new conjugates, comparative studies on in vitro cytotoxicities, plasma stabilities, in vivo pharmacokinetic properties, and maximum tolerated doses were then carried out to identify a potent ZnDPA-based SN-38 conjugate that resulted in pancreatic cancer growth regression with an 80% reduction of cytotoxic payload used when compared to that of the marketed irinotecan. Our work provided the roadmap to construct a variety of theranostic agents in a similar manner for cancer treatment.Keywords
This publication has 31 references indexed in Scilit:
- Development of nanoliposomal irinotecan (nal-IRI, MM-398, PEP02) in the management of metastatic pancreatic cancerExpert Opinion on Pharmacotherapy, 2016
- Antibody–Drug Conjugates and Small Molecule–Drug Conjugates: Opportunities and Challenges for the Development of Selective Anticancer Cytotoxic AgentsJournal of Medicinal Chemistry, 2015
- Perspectives on Biologically Active Camptothecin DerivativesMedicinal Research Reviews, 2015
- Principles in the design of ligand-targeted cancer therapeutics and imaging agentsNature Reviews Drug Discovery, 2015
- A Small‐Molecule Drug Conjugate for the Treatment of Carbonic Anhydrase IX Expressing TumorsAngewandte Chemie International Edition, 2014
- Enhanced Cell Death Imaging Using Multivalent Zinc(II)-bis(dipicolylamine) Fluorescent ProbesMolecular Pharmaceutics, 2013
- Nanoparticle therapeutics for prostate cancer treatmentNanomedicine: Nanotechnology, Biology and Medicine, 2012
- Optical Imaging of Mammary and Prostate Tumors in Living Animals using a Synthetic Near Infrared Zinc(II)-Dipicolylamine Probe for Anionic Cell SurfacesJournal of the American Chemical Society, 2009
- Tumor-derived microvesicles modulate the establishment of metastatic melanoma in a phosphatidylserine-dependent mannerCancer Letters, 2009
- Preclinical Antitumor Activity of a Novel Folate-Targeted Dual Drug ConjugateMolecular Pharmaceutics, 2007